title: Recurrent Klebsiella pneumoniae liver abscess: clinical and microbiological characteristics.
abstract: Recurrent Klebsiella pneumoniae liver abscesses (KLAs) are rarely reported. Six cases of recurrent KLAs are characterized. Most of the patients had diabetes and K1 serotype KLAs. All of the isolates were uniformly susceptible to cefazolin. Distinct molecular fingerprints were found for the strains isolated from both primary and recurrent KLAs.
authors.affiliation: Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
authors.forename: Ya-Sung
authors.initials: YS
authors.lastname: Yang
authors.forename: L K
authors.initials: LK
authors.lastname: Siu
authors.forename: Kuo-Ming
authors.initials: KM
authors.lastname: Yeh
authors.forename: Chang-Phong
authors.initials: CP
authors.lastname: Fung
authors.forename: Shenq-Jie
authors.initials: SJ
authors.lastname: Huang
authors.forename: Han-Chang
authors.initials: HC
authors.lastname: Hung
authors.forename: Jung-Chung
authors.initials: JC
authors.lastname: Lin
authors.forename: Feng-Yee
authors.initials: FY
authors.lastname: Chang
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015373:Bacterial Typing Techniques; D002437:Cefazolin / Q000494:pharmacology; D016000:Cluster Analysis; D016172:DNA Fingerprinting; D048909:Diabetes Complications; D016521:Electrophoresis, Gel, Pulsed-Field; D005260:Female; D005838:Genotype; D006801:Humans; D007710:Klebsiella Infections / Q000175:diagnosis*; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D008100:Liver Abscess / Q000382:microbiology*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D017720:Molecular Epidemiology; D012008:Recurrence
chemical_list: D000900:Anti-Bacterial Agents; D002437:Cefazolin
references.citation: J Infect Dis. 2000 Jun;181(6):2075-9
references.pmid: 10837197
references.citation: QJM. 2002 Dec;95(12):797-802
references.pmid: 12454322
references.citation: Am J Gastroenterol. 2005 Feb;100(2):322-31
references.pmid: 15667489
references.citation: Clin Infect Dis. 2007 May 1;44(9):1194-201
references.pmid: 17407038
references.citation: Microbes Infect. 2004 Nov;6(13):1191-8
references.pmid: 15488738
references.citation: Clin Infect Dis. 2004 Dec 1;39(11):1654-9
references.pmid: 15578367
references.citation: Clin Microbiol Rev. 1998 Oct;11(4):589-603
references.pmid: 9767057
references.citation: Antimicrob Agents Chemother. 2003 Jul;47(7):2088-92
references.pmid: 12821451
references.citation: J Clin Microbiol. 2007 Feb;45(2):466-71
references.pmid: 17151209
references.citation: Diabet Med. 1997 Jan;14(1):29-34
references.pmid: 9017350
references.citation: Diagn Microbiol Infect Dis. 2008 Sep;62(1):1-6
references.pmid: 18486404
references.citation: Gut. 2002 Mar;50(3):420-4
references.pmid: 11839725
references.citation: J Clin Endocrinol Metab. 2006 Aug;91(8):3084-7
references.pmid: 16720670
references.citation: Mol Genet Metab. 2001 Jul;73(3):259-67
references.pmid: 11461193
references.citation: Clin Infect Dis. 1998 Jun;26(6):1434-8
references.pmid: 9636876
references.citation: J Antimicrob Chemother. 2001 Jun;47(6):755-61
references.pmid: 11389107